Product Information

AMLODIPINE BESYLATE 2.5 MG TAB is a generic product labeled by Oxford Pharmaceuticals, LLC, priced at $0.0111 per EA under NDC 69584002109. Its NADAC has been published 218 times since Sep 14, 2022.

FDA first approved this application on Apr 7, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE BESYLATE 2.5 MG TAB

AMLODIPINE BESYLATE
$0.0111per EA

Strength

2.5 mg/1

NDC

69584002109

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

AMLODIPINE BESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078414

FDA Approved

4/7/2010

TE Code

AB

On Market Since

10/1/2021

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has been published 218 times since Sep 14, 2022, and over the history we have for it it has declined 21.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0111 per EA
All-time high$0.0172 (Nov 16, 2022)
All-time low$0.0085 (Nov 20, 2024)
52-week high$0.0114
52-week low$0.0102
Median price$0.0111
Average price$0.0122
Largest weekly change+34.0% (Aug 21, 2024)
Weeks tracked218
Tracking sinceSep 14, 2022

Price History

1W

0.0%

1M

+4.2%

3M

+8.6%

6M

-2.8%

1Y

+6.6%

3Y

-12.8%

5Y

N/A

All

-21.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE BESYLATE 2.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE BESYLATE 2.5 MG TAB, manufactured by Oxford Pharmaceuticals, LLC, is $0.0111 per EA (NDC 69584002109), effective Nov 11, 2026.

How has the price of AMLODIPINE BESYLATE 2.5 MG TAB changed over time?

Over the history we have for it, the NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has declined 21.3%. It has been tracked across 218 weekly CMS publications since Sep 14, 2022.

What are the highest and lowest recorded NADAC prices for AMLODIPINE BESYLATE 2.5 MG TAB?

Since Sep 14, 2022, the NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has ranged from a low of $0.0085 (Nov 20, 2024) to a high of $0.0172 (Nov 16, 2022), with a median of $0.0111 per EA.

Are there cheaper alternatives to AMLODIPINE BESYLATE 2.5 MG TAB?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE BESYLATE 2.5 MG TAB, is $0.0103 per EA — about 7% below AMLODIPINE BESYLATE 2.5 MG TAB.

Who manufactures AMLODIPINE BESYLATE 2.5 MG TAB?

AMLODIPINE BESYLATE 2.5 MG TAB (NDC 69584002109) is labeled by Oxford Pharmaceuticals, LLC, and CMS classifies it as a generic product.